Merck announces Rs 17.85 crores caring aid to India for COVID relief
Mumbai: Merck has recently announced its support to India in combating the recent surge in Covid-19 cases.
With the country grappling with increasing number of cases of novel coronavirus and people facing shortage of oxygen cylinders, hospital beds and drug supplies, Merck has extended its support to help India in its fight against Covid-19 and has announced 2 million Euros (INR 17.85 crores) as a caring aid.
The aid is being utilized for procuring equipment of 250 oxygen concentrators, 100 ventilator units, and setting up oxygen generation plants in four hospitals.
"Merck India is working with state governments, government departments and non-profit service organizations managing Covid care for putting this aid to use of people who may be needing it the most. A part of this aid will also be utilised to procure medicines for emergency care of employees and their families," the company said.
Sunil Punjabi, Country Speaker and Head of Research Solutions, Life Science says "The second wave of Covid-19 infection has hugely impacted life and the economy. As an organisation our top priority in these challenging times is health and safety for all. While we remain committed to the safety of our employees, it is our responsibility to do our part to help ease the situation in the country. We are happy to extend this care and are confident that our aid will be supplementing the government's efforts in addressing the need of the patients. We will continue to stand together for India, united by our clear commitment to fight the pandemic."
As part of its regular CSR activities, Merck had earlier donated over 160,000 face masks, disinfectants and thermal temperature scanners to the frontline and health departments as well as dry rations to migrant worker families around its manufacturing sites. The company has also contributed to the state relief funds in the Karnataka and Maharashtra, and the PM Care fund, towards Covid relief.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.